nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Rash generalised—Vemurafenib—melanoma	0.0754	0.119	CcSEcCtD
Carteolol—Cerebral ischaemia—Temozolomide—melanoma	0.0339	0.0537	CcSEcCtD
Carteolol—Rash generalised—Docetaxel—melanoma	0.0256	0.0406	CcSEcCtD
Carteolol—Lacrimation—Docetaxel—melanoma	0.0185	0.0293	CcSEcCtD
Carteolol—Respiratory failure—Temozolomide—melanoma	0.0167	0.0264	CcSEcCtD
Carteolol—Cerebrovascular accident—Bleomycin—melanoma	0.0144	0.0228	CcSEcCtD
Carteolol—Diabetes mellitus—Carmustine—melanoma	0.0142	0.0224	CcSEcCtD
Carteolol—Dysgeusia—Vemurafenib—melanoma	0.0137	0.0217	CcSEcCtD
Carteolol—Eye irritation—Docetaxel—melanoma	0.0128	0.0202	CcSEcCtD
Carteolol—Diplopia—Carmustine—melanoma	0.0123	0.0195	CcSEcCtD
Carteolol—Bronchospasm—Bleomycin—melanoma	0.012	0.019	CcSEcCtD
Carteolol—Diplopia—Temozolomide—melanoma	0.0119	0.0188	CcSEcCtD
Carteolol—Lacrimation increased—Docetaxel—melanoma	0.0118	0.0187	CcSEcCtD
Carteolol—Respiratory failure—Docetaxel—melanoma	0.0111	0.0176	CcSEcCtD
Carteolol—Hypotension—Vemurafenib—melanoma	0.0107	0.0169	CcSEcCtD
Carteolol—Depression—Carmustine—melanoma	0.00946	0.015	CcSEcCtD
Carteolol—Depression—Temozolomide—melanoma	0.00914	0.0145	CcSEcCtD
Carteolol—Cardiac failure congestive—Docetaxel—melanoma	0.00873	0.0138	CcSEcCtD
Carteolol—Sinusitis—Temozolomide—melanoma	0.0086	0.0136	CcSEcCtD
Carteolol—Hypersensitivity—Vemurafenib—melanoma	0.00843	0.0133	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—melanoma	0.00835	0.0132	CcSEcCtD
Carteolol—Asthenia—Vemurafenib—melanoma	0.00821	0.013	CcSEcCtD
Carteolol—Visual impairment—Carmustine—melanoma	0.00821	0.013	CcSEcCtD
Carteolol—Visual impairment—Temozolomide—melanoma	0.00793	0.0126	CcSEcCtD
Carteolol—Arrhythmia—Carmustine—melanoma	0.00761	0.012	CcSEcCtD
Carteolol—Dizziness—Vemurafenib—melanoma	0.00757	0.012	CcSEcCtD
Carteolol—Headache—Vemurafenib—melanoma	0.00717	0.0113	CcSEcCtD
Carteolol—Dysgeusia—Temozolomide—melanoma	0.00702	0.0111	CcSEcCtD
Carteolol—Vision blurred—Carmustine—melanoma	0.00699	0.0111	CcSEcCtD
Carteolol—Oedema—Bleomycin—melanoma	0.00693	0.011	CcSEcCtD
Carteolol—Nausea—Vemurafenib—melanoma	0.0068	0.0108	CcSEcCtD
Carteolol—Vision blurred—Temozolomide—melanoma	0.00675	0.0107	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—melanoma	0.00673	0.0106	CcSEcCtD
Carteolol—Hypotension—Bleomycin—melanoma	0.00648	0.0103	CcSEcCtD
Carteolol—Oedema—Dactinomycin—melanoma	0.00647	0.0102	CcSEcCtD
Carteolol—Palpitations—Temozolomide—melanoma	0.00633	0.01	CcSEcCtD
Carteolol—Dyspnoea—Bleomycin—melanoma	0.00618	0.00978	CcSEcCtD
Carteolol—Oedema—Carmustine—melanoma	0.00605	0.00958	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—melanoma	0.00593	0.00938	CcSEcCtD
Carteolol—Oedema—Temozolomide—melanoma	0.00585	0.00925	CcSEcCtD
Carteolol—Hypotension—Carmustine—melanoma	0.00565	0.00895	CcSEcCtD
Carteolol—Insomnia—Carmustine—melanoma	0.00547	0.00866	CcSEcCtD
Carteolol—Dyspnoea—Carmustine—melanoma	0.0054	0.00854	CcSEcCtD
Carteolol—Insomnia—Temozolomide—melanoma	0.00529	0.00837	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—melanoma	0.00528	0.00835	CcSEcCtD
Carteolol—Dyspnoea—Temozolomide—melanoma	0.00521	0.00825	CcSEcCtD
Carteolol—Hypersensitivity—Bleomycin—melanoma	0.00511	0.00808	CcSEcCtD
Carteolol—Asthenia—Bleomycin—melanoma	0.00497	0.00787	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—melanoma	0.00489	0.00774	CcSEcCtD
Carteolol—Hypersensitivity—Dactinomycin—melanoma	0.00476	0.00754	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—melanoma	0.00467	0.00738	CcSEcCtD
Carteolol—Asthenia—Dactinomycin—melanoma	0.00464	0.00734	CcSEcCtD
Carteolol—Hypersensitivity—Carmustine—melanoma	0.00446	0.00705	CcSEcCtD
Carteolol—Asthenia—Carmustine—melanoma	0.00434	0.00687	CcSEcCtD
Carteolol—Hypersensitivity—Temozolomide—melanoma	0.00431	0.00682	CcSEcCtD
Carteolol—Syncope—Docetaxel—melanoma	0.00427	0.00676	CcSEcCtD
Carteolol—Palpitations—Docetaxel—melanoma	0.00421	0.00666	CcSEcCtD
Carteolol—Asthenia—Temozolomide—melanoma	0.0042	0.00664	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—melanoma	0.00419	0.00663	CcSEcCtD
Carteolol—Nausea—Bleomycin—melanoma	0.00412	0.00652	CcSEcCtD
Carteolol—Dizziness—Carmustine—melanoma	0.004	0.00633	CcSEcCtD
Carteolol—Oedema—Docetaxel—melanoma	0.00389	0.00615	CcSEcCtD
Carteolol—Dizziness—Temozolomide—melanoma	0.00387	0.00612	CcSEcCtD
Carteolol—Nausea—Dactinomycin—melanoma	0.00384	0.00608	CcSEcCtD
Carteolol—Shock—Docetaxel—melanoma	0.00383	0.00605	CcSEcCtD
Carteolol—Headache—Carmustine—melanoma	0.00379	0.006	CcSEcCtD
Carteolol—Headache—Temozolomide—melanoma	0.00366	0.0058	CcSEcCtD
Carteolol—Hypotension—Docetaxel—melanoma	0.00363	0.00575	CcSEcCtD
Carteolol—Nausea—Carmustine—melanoma	0.00359	0.00569	CcSEcCtD
Carteolol—Insomnia—Docetaxel—melanoma	0.00352	0.00557	CcSEcCtD
Carteolol—Nausea—Temozolomide—melanoma	0.00347	0.0055	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—melanoma	0.00347	0.00549	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—melanoma	0.00287	0.00453	CcSEcCtD
Carteolol—Asthenia—Docetaxel—melanoma	0.00279	0.00442	CcSEcCtD
Carteolol—Dizziness—Docetaxel—melanoma	0.00257	0.00407	CcSEcCtD
Carteolol—Headache—Docetaxel—melanoma	0.00244	0.00386	CcSEcCtD
Carteolol—Nausea—Docetaxel—melanoma	0.00231	0.00366	CcSEcCtD
Carteolol—ADRB1—Signaling Pathways—BCL2L11—melanoma	0.000318	0.000863	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BCL2L11—melanoma	0.000311	0.000844	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RHOB—melanoma	0.000311	0.000844	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HDAC6—melanoma	0.000305	0.000829	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—EDN1—melanoma	0.000302	0.000821	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HDAC6—melanoma	0.000298	0.000811	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—EDN1—melanoma	0.000296	0.000803	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CSF2—melanoma	0.000295	0.000803	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLCB4—melanoma	0.000295	0.000802	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCR2—melanoma	0.000289	0.000786	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CXCL8—melanoma	0.000289	0.000786	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CSF2—melanoma	0.000289	0.000785	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RAC2—melanoma	0.000285	0.000773	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PRKCA—melanoma	0.000283	0.00077	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCR2—melanoma	0.000283	0.000769	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CXCL8—melanoma	0.000283	0.000768	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—WNT5A—melanoma	0.00028	0.000761	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFC—melanoma	0.00028	0.000761	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RAC2—melanoma	0.000278	0.000756	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC6A11—melanoma	0.000277	0.000754	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIP4K2A—melanoma	0.000277	0.000754	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCA—melanoma	0.000277	0.000753	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EDN1—melanoma	0.000274	0.000746	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFC—melanoma	0.000274	0.000745	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—WNT5A—melanoma	0.000274	0.000745	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTAP—melanoma	0.00027	0.000733	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EDN1—melanoma	0.000268	0.00073	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CSF2—melanoma	0.000268	0.000729	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—RAC1—melanoma	0.000263	0.000714	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CSF2—melanoma	0.000262	0.000713	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCA—melanoma	0.000257	0.000699	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—RAC1—melanoma	0.000257	0.000698	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCA—melanoma	0.000252	0.000684	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAP2K2—melanoma	0.000251	0.000683	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAP2K2—melanoma	0.000246	0.000668	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—F2R—melanoma	0.000246	0.000668	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—F2R—melanoma	0.000241	0.000654	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PHGDH—melanoma	0.000241	0.000654	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LUM—melanoma	0.000241	0.000654	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—RAC1—melanoma	0.000238	0.000648	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDNRB—melanoma	0.000238	0.000647	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HPSE—melanoma	0.000236	0.000641	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—RAC1—melanoma	0.000233	0.000634	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDNRB—melanoma	0.000233	0.000633	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CUBN—melanoma	0.000232	0.000629	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTK2B—melanoma	0.000231	0.000628	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTK2B—melanoma	0.000226	0.000615	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAB2—melanoma	0.000225	0.000611	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNA11—melanoma	0.000225	0.000611	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FLT1—melanoma	0.000224	0.000609	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SDHD—melanoma	0.000224	0.000608	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BSG—melanoma	0.000224	0.000608	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CSPG4—melanoma	0.000224	0.000608	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	0.000222	0.000603	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAB2—melanoma	0.00022	0.000598	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNA11—melanoma	0.00022	0.000598	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FLT1—melanoma	0.000219	0.000595	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	0.000217	0.00059	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPAM—melanoma	0.000217	0.000588	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCR4—melanoma	0.000211	0.000575	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FOXO4—melanoma	0.000211	0.000575	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HDAC2—melanoma	0.000211	0.000575	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNAQ—melanoma	0.000209	0.000568	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HDAC2—melanoma	0.000207	0.000562	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FOXO4—melanoma	0.000207	0.000562	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCR4—melanoma	0.000207	0.000562	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNAQ—melanoma	0.000205	0.000556	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	0.000201	0.000547	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	0.000197	0.000536	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SYK—melanoma	0.000197	0.000534	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	0.000195	0.00053	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ITGAV—melanoma	0.000193	0.000524	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NGFR—melanoma	0.000193	0.000524	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT3—melanoma	0.000193	0.000524	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SYK—melanoma	0.000192	0.000523	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	0.000191	0.000518	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NGFR—melanoma	0.000189	0.000513	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ITGAV—melanoma	0.000189	0.000513	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT3—melanoma	0.000189	0.000513	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G6—melanoma	0.000184	0.0005	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS1—melanoma	0.000179	0.000486	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	0.000178	0.000484	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—S100B—melanoma	0.000178	0.000484	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	0.000177	0.000481	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS1—melanoma	0.000175	0.000475	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	0.000174	0.000474	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—S100B—melanoma	0.000174	0.000474	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	0.000173	0.000471	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB4—melanoma	0.00017	0.000463	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	0.00017	0.000462	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	0.000169	0.000459	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB4—melanoma	0.000167	0.000453	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	0.000166	0.000452	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—VCAN—melanoma	0.000165	0.000449	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	0.000165	0.000449	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CD86—melanoma	0.000163	0.000444	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	0.000163	0.000444	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDN1—melanoma	0.000162	0.000441	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CD86—melanoma	0.00016	0.000434	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	0.00016	0.000434	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDN1—melanoma	0.000159	0.000431	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF1—melanoma	0.000158	0.000431	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CSF2—melanoma	0.000158	0.000431	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—IL2—melanoma	0.000156	0.000424	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—E2F1—melanoma	0.000155	0.000421	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CSF2—melanoma	0.000155	0.000421	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF1—melanoma	0.000155	0.000421	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	0.000154	0.000419	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	0.000153	0.000417	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—IL2—melanoma	0.000153	0.000415	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ITGB3—melanoma	0.000152	0.000413	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCA—melanoma	0.000152	0.000413	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—E2F1—melanoma	0.000152	0.000412	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	0.000151	0.00041	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	0.00015	0.000408	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SPP1—melanoma	0.000149	0.000405	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000149	0.000404	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000149	0.000404	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	0.000149	0.000404	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	0.000148	0.000403	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SPP1—melanoma	0.000146	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.000145	0.000395	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.000145	0.000394	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL2—melanoma	0.000142	0.000385	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TERT—melanoma	0.000141	0.000384	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RAC1—melanoma	0.000141	0.000383	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP17A1—melanoma	0.00014	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL2—melanoma	0.000139	0.000377	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TERT—melanoma	0.000138	0.000375	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RAC1—melanoma	0.000138	0.000374	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HIF1A—melanoma	0.000135	0.000367	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HIF1A—melanoma	0.000132	0.000359	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNA11—melanoma	0.000132	0.000358	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KDR—melanoma	0.000129	0.000351	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FASN—melanoma	0.000129	0.00035	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC5A5—melanoma	0.000127	0.000345	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KDR—melanoma	0.000126	0.000343	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FN1—melanoma	0.000124	0.000338	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD44—melanoma	0.000123	0.000333	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNAQ—melanoma	0.000123	0.000333	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	0.000122	0.000331	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FN1—melanoma	0.000122	0.000331	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CD80—melanoma	0.000119	0.000324	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	0.000119	0.000324	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	0.000119	0.000323	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KIT—melanoma	0.000119	0.000323	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APC—melanoma	0.000119	0.000323	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NRAS—melanoma	0.000119	0.000323	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGF—melanoma	0.000118	0.00032	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP1B1—melanoma	0.000117	0.000319	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CD80—melanoma	0.000117	0.000317	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APC—melanoma	0.000116	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KIT—melanoma	0.000116	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	0.000116	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NRAS—melanoma	0.000116	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGF—melanoma	0.000115	0.000313	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	0.000114	0.00031	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BRAF—melanoma	0.000112	0.000304	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	0.000111	0.000303	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BRAF—melanoma	0.000109	0.000297	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—melanoma	0.000109	0.000296	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	0.000108	0.000295	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EGFR—melanoma	0.000108	0.000295	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—melanoma	0.000107	0.00029	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	0.000106	0.000288	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EGFR—melanoma	0.000106	0.000288	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	0.000105	0.000286	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	0.000105	0.000284	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	0.000104	0.000282	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	0.000103	0.00028	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KRAS—melanoma	0.000102	0.000278	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	0.000102	0.000278	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	0.000101	0.000275	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KRAS—melanoma	0.0001	0.000272	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF2—melanoma	0.0001	0.000272	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF2—melanoma	9.8e-05	0.000266	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCB1—melanoma	9.67e-05	0.000263	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	9.41e-05	0.000256	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MDM2—melanoma	9.37e-05	0.000255	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB2—melanoma	9.24e-05	0.000251	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	9.21e-05	0.00025	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MDM2—melanoma	9.17e-05	0.000249	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	9.12e-05	0.000248	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB2—melanoma	9.04e-05	0.000246	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	8.92e-05	0.000242	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PRKCA—melanoma	8.9e-05	0.000242	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ERCC2—melanoma	8.83e-05	0.00024	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—melanoma	8.76e-05	0.000238	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRAS—melanoma	8.71e-05	0.000237	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—melanoma	8.57e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	8.56e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRAS—melanoma	8.52e-05	0.000231	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	8.47e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—melanoma	8.39e-05	0.000228	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL2—melanoma	8.37e-05	0.000228	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	8.37e-05	0.000227	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—melanoma	8.33e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	8.28e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—melanoma	8.2e-05	0.000223	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL2—melanoma	8.19e-05	0.000223	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—melanoma	8.16e-05	0.000222	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—melanoma	8.15e-05	0.000222	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	8.08e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—melanoma	7.99e-05	0.000217	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—melanoma	7.93e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	7.91e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	7.9e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTEN—melanoma	7.88e-05	0.000214	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKB1—melanoma	7.84e-05	0.000213	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—melanoma	7.75e-05	0.000211	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	7.73e-05	0.00021	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTEN—melanoma	7.71e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—melanoma	7.69e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKB1—melanoma	7.67e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—melanoma	7.52e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—melanoma	7.12e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—melanoma	7.05e-05	0.000192	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRAS—melanoma	7.03e-05	0.000191	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—melanoma	6.97e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—melanoma	6.96e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—melanoma	6.89e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRAS—melanoma	6.88e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK3—melanoma	6.73e-05	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—melanoma	6.73e-05	0.000183	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK3—melanoma	6.59e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—melanoma	6.55e-05	0.000178	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK1—melanoma	6.41e-05	0.000174	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—melanoma	6.41e-05	0.000174	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGFR—melanoma	6.41e-05	0.000174	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK1—melanoma	6.27e-05	0.00017	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGFR—melanoma	6.27e-05	0.00017	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CD—melanoma	6.13e-05	0.000167	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KRAS—melanoma	6.05e-05	0.000164	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—melanoma	6.05e-05	0.000164	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KRAS—melanoma	5.92e-05	0.000161	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	5.56e-05	0.000151	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	5.44e-05	0.000148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—melanoma	5.38e-05	0.000146	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CB—melanoma	5.34e-05	0.000145	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—melanoma	5.29e-05	0.000144	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—melanoma	5.26e-05	0.000143	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRAS—melanoma	5.14e-05	0.00014	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRAS—melanoma	5.03e-05	0.000137	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—melanoma	4.92e-05	0.000134	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—melanoma	4.82e-05	0.000131	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTEN—melanoma	4.62e-05	0.000125	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—melanoma	4.54e-05	0.000123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—melanoma	4.44e-05	0.000121	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—melanoma	3.26e-05	8.85e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—melanoma	2.66e-05	7.23e-05	CbGpPWpGaD
